JH Antin - Concepedia

Author

JH Antin

Brigham and Women's Hospital

Also Known As

J Antin, J. Antin, JH Antin

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Dana-Farber Cancer Institute Harvard University University of Michigan Boston Children's Museum

About

JH Antin is an author at Brigham and Women's Hospital specializing in medicine, cell transplantation, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	124
2	Immunology	2	2	82
3	Blood Transplantation	1	1	19
4	Marrow Transplantation	1	1	19
5	Pathology	1	1	19

JH Antin

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Cytokine dysregulation and acute graft-versus-host disease JH Antin, JL Ferrara Blood	1992	576
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor MA Goldberg, JH Antin, EC Guinan, Blood	1986	357
Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndrome JH Antin, Smith Br, W. N. Holmes, Blood	1988	299
Graft-versus-leukemia: no longer an epiphenomenon [editorial] JH Antin Blood	1993	192
Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components Donna L Fountain, Maria S. Ralston, Nancy Higgins, Transfusion	1997	192
Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia MS Roth, JH Antin, EL Bingham, Blood	1989	172
Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia MS Roth, JH Antin, Robert C. Ash, Blood	1992	142
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease JH Antin, HJ Weinstein, EC Guinan, Blood	1994	142
Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies JH Antin, B R Smith, James L.M. Ferrara, Blood	1991	128
Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? MA Goldberg, D Ginsburg, R. John Mayer, Blood	1987	108

Page 1